| 2013 | Geneva, Switzerland | Cornelia Bargmann | Rockefeller University, US | Rockefeller University, US | “For the genetics of neural circuits and behavior, and synaptic guidepost molecules.” |
| 2013 | Geneva, Switzerland | David Botstein | Princeton University, US | Princeton University, US (Deceased) | “For linkage mapping of Mendelian disease in humans using DNA polymorphisms.” |
| 2013 | Geneva, Switzerland | Lewis C. Cantley | Weill Cornell Medical College, US | Dana–Farber Cancer Institute, US | “For the discovery of PI 3-Kinase and its role in cancer metabolism.” |
| 2013 | Geneva, Switzerland | Hans Clevers | Hubrecht Institute, Netherlands | Hubrecht Institute, Netherlands | “For describing the role of Wnt signaling in tissue stem cells and cancer.” |
| 2013 | Geneva, Switzerland | Titia de Lange | Rockefeller University, US | Rockefeller University, US | “For research on telomeres, illuminating how they protect chromosome ends and their role in genome instability in cancer.” |
| 2013 | Geneva, Switzerland | Napoleone Ferrara | University of California, San Diego, US | University of California, San Diego, US | “For discoveries in the mechanisms of angiogenesis that led to therapies for cancer and eye diseases.” |
| 2013 | Geneva, Switzerland | Eric S. Lander | Broad Institute of MIT and Harvard, US | Broad Institute, US | “For the discovery of general principles for identifying human disease genes.” |
| 2013 | Geneva, Switzerland | Charles L. Sawyers | Memorial Sloan Kettering Cancer Center, US | Memorial Sloan Kettering Cancer Center, US | “For cancer genes and targeted therapy.” |
| 2013 | Geneva, Switzerland | Robert A. Weinberg | Massachusetts Institute of Technology, US | Massachusetts Institute of Technology, US | “For characterization of human cancer genes.” |
| 2013 | Geneva, Switzerland | Shinya Yamanaka (山中伸弥) | Kyoto University, Japan | Kyoto University, Japan | “For induced pluripotent stem cells.” |
| 2013 | Geneva, Switzerland | Bert Vogelstein | Johns Hopkins University, US | Johns Hopkins University, US | “For cancer genomics and tumor suppressor genes.” |
| 2014 | Mountain View, US | James P. Allison | MD Anderson Cancer Center, US | MD Anderson Cancer Center, US | “For the discovery of T cell checkpoint blockade as effective cancer therapy.” |
| 2014 | Mountain View, US | Mahlon DeLong | Emory University, US | Emory University, US | “For defining the interlocking circuits in the brain that malfunction in Parkinson’s disease.” |
| 2014 | Mountain View, US | Michael N. Hall | University of Basel, Switzerland | University of Basel, Switzerland | “For the discovery of Target of Rapamycin (TOR) and its role in cell growth control.” |
| 2014 | Mountain View, US | Robert Langer | Massachusetts Institute of Technology, US | Massachusetts Institute of Technology, US | “For discoveries leading to the development of controlled drug-release systems and new biomaterials.” |
| 2014 | Mountain View, US | Richard P. Lifton | Yale University, US | Rockefeller University, US | “For the discovery of genes and biochemical mechanisms that cause hypertension.” |
| 2015 | Mountain View, US | Alim Louis Benabid | Joseph Fourier University, France | Joseph Fourier University, France | “For the discovery and development of deep brain stimulation (DBS), which has revolutionized the treatment of Parkinson’s disease.” |
| 2015 | Mountain View, US | C. David Allis | Rockefeller University, US | Rockefeller University, US (Deceased) | “For the discovery of covalent modifications of histone proteins and their critical roles in the regulation of gene expression.” |
| 2015 | Mountain View, US | Victor Ambros | University of Massachusetts Medical School, US | University of Massachusetts Medical School, US | “For the discovery of a new world of genetic regulation by microRNAs.” |
| 2015 | Mountain View, US | Gary Ruvkun | Massachusetts General Hospital & Harvard, US | Harvard Medical School, US | “For the discovery of a new world of genetic regulation by microRNAs.” |
| 2015 | Mountain View, US | Jennifer Doudna | University of California, Berkeley, US | University of California, Berkeley, US | “For harnessing an ancient mechanism of bacterial immunity into a powerful and general technology for editing genomes.” |
| 2015 | Mountain View, US | Emmanuelle Charpentier | Helmholtz Centre for Infection Research, Germany | Max Planck Unit for the Science of Pathogens, Germany | “For harnessing an ancient mechanism of bacterial immunity into a powerful and general technology for editing genomes.” |
| 2016 | Mountain View, US | Edward Boyden | Massachusetts Institute of Technology, US | Massachusetts Institute of Technology, US | “For the development and implementation of optogenetics.” |
| 2016 | Mountain View, US | Karl Deisseroth | Stanford University, US | Stanford University, US | “For the development and implementation of optogenetics.” |
| 2016 | Mountain View, US | John Hardy | University College London, UK | University College London, UK | “For discovering mutations in the Amyloid Precursor Protein (APP) gene that cause early onset Alzheimer’s disease.” |
| 2016 | Mountain View, US | Helen Hobbs | University of Texas Southwestern Medical Center, US | UT Southwestern Medical Center, US | “For the discovery of human genetic variants that alter the levels and distribution of cholesterol.” |
| 2016 | Mountain View, US | Svante Pääbo | Max Planck Institute for Evolutionary Anthropology | Max Planck Institute, Germany | “For pioneering the sequencing of ancient DNA and ancient genomes.” |
| 2017 | Mountain View, US | Stephen J. Elledge | Harvard Medical School, US | Harvard Medical School, US | “For elucidating how eukaryotic cells sense and respond to damage in their DNA.” |
| 2017 | Mountain View, US | Harry F. Noller | University of California, Santa Cruz, US | University of California, Santa Cruz, US | “For discovering the centrality of RNA in the molecular machinery of protein synthesis.” |
| 2017 | Mountain View, US | Roeland Nusse | Stanford University, US | Stanford University, US | “For pioneering research on the Wnt pathway, a crucial signaling system in development and cancer.” |
| 2017 | Mountain View, US | Yoshinori Ohsumi (大隅良典) | Tokyo Institute of Technology, Japan | Tokyo Institute of Technology, Japan | “For elucidating autophagy, the recycling system that cells use to generate nutrients.” |
| 2017 | Mountain View, US | Huda Zoghbi | Baylor College of Medicine, US | Baylor College of Medicine, US | “For discoveries of the genetic causes and biochemical mechanisms of spinocerebellar ataxia and Rett syndrome.” |
| 2018 | Mountain View, US | Joanne Chory | Salk Institute for Biological Studies, US | Salk Institute for Biological Studies, US | “For discovering how plants optimize their growth, development, and cellular structure in response to light.” |
| 2018 | Mountain View, US | Don W. Cleveland | University of California, San Diego, US | University of California, San Diego, US | “For elucidating the molecular pathogenesis of a type of inherited ALS.” |
| 2018 | Mountain View, US | Kazutoshi Mori (森和俊) | Kyoto University, Japan | Kyoto University, Japan | “For elucidating the unfolded protein response, a cellular quality-control system.” |
| 2018 | Mountain View, US | Peter Walter | University of California, San Francisco, US | Altos Labs, US | “For elucidating the unfolded protein response, a cellular quality-control system.” |
| 2018 | Mountain View, US | Kim Nasmyth | University of Oxford, UK | University of Oxford, UK | “For elucidating the sophisticated mechanism that mediates the perilous separation of duplicated chromosomes during cell division.” |
| 2019 | Mountain View, US | C. Frank Bennett | Ionis Pharmaceuticals, US | Ionis Pharmaceuticals, US | “For the development of an effective antisense oligonucleotide therapy for spinal muscular atrophy.” |
| 2019 | Mountain View, US | Adrian R. Krainer | Cold Spring Harbor Laboratory, US | Cold Spring Harbor Laboratory, US | “For the development of an effective antisense oligonucleotide therapy for spinal muscular atrophy.” |
| 2019 | Mountain View, US | Angelika Amon | Massachusetts Institute of Technology, US | Massachusetts Institute of Technology, US (Deceased) | “For determining the consequences of aneuploidy, an abnormal chromosome number.” |
| 2019 | Mountain View, US | Xiaowei Zhuang | Harvard University, US | Harvard University, US | “For discovering hidden structures in cells by developing super-resolution imaging.” |
| 2019 | Mountain View, US | Zhijian Chen | UT Southwestern Medical Center, US | UT Southwestern Medical Center, US | “For elucidating how DNA triggers immune and inflammatory responses from within the cell.” |
| 2020 | Mountain View, US | Jeffrey M. Friedman | Rockefeller University, US | Rockefeller University, US | “For the discovery of a new endocrine system through which adipose tissue signals the brain to regulate food intake.” |
| 2020 | Mountain View, US | F. Ulrich Hartl | Max Planck Institute of Biochemistry, Germany | Max Planck Institute, Germany | “For discovering functions of molecular chaperones in mediating protein folding.” |
| 2020 | Mountain View, US | Arthur L. Horwich | Yale School of Medicine, US | Yale School of Medicine, US | “For discovering functions of molecular chaperones in mediating protein folding.” |
| 2020 | Mountain View, US | David Julius | University of California, San Francisco, US | University of California, San Francisco, US | “For discovering cellular mechanisms that produce pain sensations from heat, cold, and chili peppers.” |
| 2020 | Mountain View, US | Virginia Man-Yee Lee | University of Pennsylvania, US | University of Pennsylvania, US | “For discovering TDP-43 protein aggregates in frontotemporal dementia and ALS.” |
| 2021 | Los Angeles, US (Virtual) | David Baker | University of Washington, US | University of Washington, US | “For developing technology that allowed the design of macromolecular proteins never before seen in nature.” |
| 2021 | Los Angeles, US (Virtual) | Catherine Dulac | Harvard University, US | Harvard University, US | “For deconstructing the complex behavior of parenting to the level of brain cells and wiring.” |
| 2021 | Los Angeles, US (Virtual) | Dennis Lo | The Chinese University of Hong Kong | The Chinese University of Hong Kong | “For discovering that fetal DNA is present in maternal plasma and can be used for non-invasive prenatal testing.” |
| 2021 | Los Angeles, US (Virtual) | Richard J. Youle | National Institutes of Health, US | National Institutes of Health, US | “For elucidating a quality control pathway that clears damaged mitochondria and thereby protects against Parkinson’s disease.” |
| 2022 | Los Angeles, US (Virtual) | Jeffery W. Kelly | Scripps Research Institute, US | Scripps Research Institute, US | “For elucidating the molecular basis of neurodegenerative and cardiac transthyretin amyloid diseases.” |
| 2022 | Los Angeles, US (Virtual) | Katalin Karikó | BioNTech & University of Pennsylvania, US | University of Szeged, Hungary | “For engineering modified RNA technology that enabled the rapid development of effective COVID-19 vaccines.” |
| 2022 | Los Angeles, US (Virtual) | Drew Weissman | University of Pennsylvania, US | University of Pennsylvania, US | “For engineering modified RNA technology that enabled the rapid development of effective COVID-19 vaccines.” |
| 2022 | Los Angeles, US (Virtual) | Shankar Balasubramanian | University of Cambridge, UK | University of Cambridge, UK | “For the development of robust, next-generation DNA sequencing methodologies.” |
| 2022 | Los Angeles, US (Virtual) | David Klenerman | University of Cambridge, UK | University of Cambridge, UK | “For the development of robust, next-generation DNA sequencing methodologies.” |
| 2022 | Los Angeles, US (Virtual) | Pascal Mayer | Alphanosos, France | Alphanosos, France | “For the development of robust, next-generation DNA sequencing methodologies.” |
| 2023 | Los Angeles, US | Clifford P. Brangwynne | Princeton University, US | Princeton University, US | “For discovering a fundamental mechanism of cellular organization mediated by phase separation of proteins and RNA into membraneless liquid droplets.” |
| 2023 | Los Angeles, US | Anthony A. Hyman | Max Planck Institute of Molecular Cell Biology and Genetics | Max Planck Institute, Germany | “For discovering a fundamental mechanism of cellular organization mediated by phase separation of proteins and RNA into membraneless liquid droplets.” |
| 2023 | Los Angeles, US | Demis Hassabis | Google DeepMind, UK | Google DeepMind, UK | “For developing AlphaFold, which accurately predicts the 3D structure of proteins.” |
| 2023 | Los Angeles, US | John Jumper | Google DeepMind, UK | Google DeepMind, UK | “For developing AlphaFold, which accurately predicts the 3D structure of proteins.” |
| 2023 | Los Angeles, US | Emmanuel Mignot | Stanford University School of Medicine, US | Stanford University, US | “For discovering that narcolepsy is caused by the loss of a small population of brain cells that make a wake-promoting substance.” |
| 2023 | Los Angeles, US | Masashi Yanagisawa (柳沢正史) | University of Tsukuba, Japan | University of Tsukuba, Japan | “For discovering that narcolepsy is caused by the loss of a small population of brain cells that make a wake-promoting substance.” |
| 2024 | Los Angeles, US | Carl H. June | University of Pennsylvania, US | University of Pennsylvania, US | “For the development of chimeric antigen receptor T-cell (CAR-T) therapy for leukemia.” |
| 2024 | Los Angeles, US | Michel Sadelain | Memorial Sloan Kettering Cancer Center, US | Memorial Sloan Kettering Cancer Center, US | “For the development of chimeric antigen receptor T-cell (CAR-T) therapy for leukemia.” |
| 2024 | Los Angeles, US | Sabine Hadida | Vertex Pharmaceuticals, US | Vertex Pharmaceuticals, US | “For developing combination therapies that repair the defective chloride channel protein in cystic fibrosis.” |
| 2024 | Los Angeles, US | Paul Negulescu | Vertex Pharmaceuticals, US | Vertex Pharmaceuticals, US | “For developing combination therapies that repair the defective chloride channel protein in cystic fibrosis.” |
| 2024 | Los Angeles, US | Fred Van Goor | Vertex Pharmaceuticals, US | Vertex Pharmaceuticals, US | “For developing combination therapies that repair the defective chloride channel protein in cystic fibrosis.” |
| 2024 | Los Angeles, US | Thomas Gasser | Hertie Institute for Clinical Brain Research, Germany | University of Tübingen, Germany | “For identifying the most common genetic risk factors for Parkinson’s disease.” |
| 2024 | Los Angeles, US | Ellen Sidransky | National Human Genome Research Institute, US | National Institutes of Health, US | “For identifying the most common genetic risk factors for Parkinson’s disease.” |
| 2024 | Los Angeles, US | Andrew Singleton | National Institute on Aging, US | National Institutes of Health, US | “For identifying the most common genetic risk factors for Parkinson’s disease.” |
| 2025 | Los Angeles, US | – (List Ongoing for 2025/2026 updates) | – | – | Updated per cohort releases in medical genomics and cellular pathways. |
| 2026 | Los Angeles, US | Jean Bennett | University of Pennsylvania, US | University of Pennsylvania, US | “For developing the first gene replacement therapy approved by the U.S. FDA, targeting rare inherited blindness.” |
| 2026 | Los Angeles, US | Katherine High | University of Pennsylvania, US | AskBio, US | “For developing the first gene replacement therapy approved by the U.S. FDA, targeting rare inherited blindness.” |
| 2026 | Los Angeles, US | Albert Maguire | University of Pennsylvania, US | University of Pennsylvania, US | “For developing the first gene replacement therapy approved by the U.S. FDA, targeting rare inherited blindness.” |
| 2026 | Los Angeles, US | Stuart H. Orkin | Harvard Medical School, US | Harvard Medical School, US | “For discoveries that led to gene-editing treatments for sickle cell disease and beta-thalassemia.” |
| 2026 | Los Angeles, US | Swee Lay Thein | National Institutes of Health, US | National Institutes of Health, US | “For discoveries that led to gene-editing treatments for sickle cell disease and beta-thalassemia.” |
| 2026 | Los Angeles, US | Rosa Rademakers | VIB-UAntwerp Center for Molecular Neurology | VIB-UAntwerp, Belgium | “For uncovering a major genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.” |
| 2026 | Los Angeles, US | Bryan Traynor | National Institute on Aging, US | National Institutes of Health, US | “For uncovering a major genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.” |
